Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma

Background/Aims: Several studies have suggested that surgical resection (SR) can provide a survival benefit over transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) at the intermediate stage according to the Barcelona Clinic Liver Cancer (BCLC) staging system. However, the crit...

Full description

Bibliographic Details
Main Authors: Jun Young Kim, Dong Hyun Sinn, Geum-Youn Gwak, Gyu-Seong Choi, Aldosri Meshal Saleh, Jae-Won Joh, Sung Ki Cho, Sung Wook Shin, Keumhee Chough Carriere, Joong Hyun Ahn, Yong-Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2016-06-01
Series:Clinical and Molecular Hepatology
Subjects:
Hepatocellular carcinoma
Intermediate stage
Transarterial chemoembolization
Resection
Survival
Online Access:http://e-cmh.org/upload/pdf/cmh-2016-0015.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-2016-0015.pdf

Similar Items